PRESTON PETERSON: Open Payments
NPI 1801453030 · SPARKS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$773 in 23 payments from 13 companies in 2025. Trend: 2023 $417 · 2024 $2,180 · 2025 $773
Food & beverage: $773
| Company | Payments | Amount |
|---|---|---|
| Edwards Lifesciences Corporation | 2 | $197 |
| HEARTFLOW, INC. | 2 | $98 |
| Medtronic, Inc. | 1 | $88 |
| Alnylam Pharmaceuticals Inc. | 3 | $78 |
| Novartis Pharmaceuticals Corporation | 3 | $68 |
| PFIZER INC. | 3 | $53 |
| AtriCure, Inc. | 2 | $47 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $37 |
| Merck Sharp & Dohme LLC | 1 | $32 |
| Avadel CNS Pharmaceuticals, LLC | 1 | $28 |
Products named: PASCAL, FFRct, SYMPLICITY G3, AMVUTTRA, SAPIEN 3 Ultra RESILIA, LEQVIO, ATRICLIP LAA EXCLUSION SYSTEM, Kerendia.
Industry payments across NV — which companies pay providers there.
